Global private equity healthcare specialist ARCHIMED announces the acquisition of a majority stake in Cellese, a developer of innovative topical dermo cosmetics sold under the AnteAGE brand name. Cellese products aid in skin rejuvenation. Located in Irvine, California and founded in 2009, Cellese’s cornerstone technology is based on harnessing the body’s natural regenerative properties using growth factors, exosomes and biosomes™. Cellese products are distributed and sold through dermatologists’ offices and aesthetic clinics. They are applied when patients receive radio frequency, laser and microneedling treatments, or at home to promote skin longevity.
Read the full article: ARCHIMED Buys Cellese, a Pioneering Developer of Growth Factors and Exosome-Based Skincare Products //
Source: https://www.archimed.group/news/archimed-buys-cellese-a-pioneering-developer-of-growth-factors-and-exosome-based-skincare-products/